Recursion Pharmaceuticals Inc RXRX

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

[Jonathon Brown]

A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results. read article.

[PressRelease]

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find...read article.

[Keepdigging]

RXRX is selling off in tax loss season. Keep an eye on it for the bottom, accumulate. Looks like  2025 could be the year for results on several fronts.

[Humanist]

Recursion Announces the Release of OpenPhenom-S/16 in Google Cloud’s Model Garden Recursion Pharmaceuticals, Inc. Tue, November 12, 2024 at 4:54 PM EST 6 min read RXRX -3.43% Recursion

[Humanist]

Recursion and Exscientia Shareholders Approve the Proposed Combination GlobeNewswire · GlobeNewswire Inc. Recursion Pharmaceuticals Wed, November 13, 2024 at 9:08 AM EST 6 min read

[Humanist]

Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results Recursion Pharmaceuticals Recursion Pharmaceuticals Wed, November 6, 2024 at 4:15 PM EST In This Article: RXRX +2

[Humanist]

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

[whytestocks]

JUST IN: $RXRX Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety

[whytestocks]

JUST IN: $RXRX Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8thSalt Lake City, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading

[MikeTester]

https://beyondspx.com/2024/08/02/recursion-pharmaceuticals-nasdaqrxrx-decoding-biology-to-industrialize-drug-discovery/

[whytestocks]

JUST IN: $RXRX Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim2024-06-07 09:00:00 ET Investing in growth stocks can lead to significant returns for

[Humanist]

IN THE PHARMACEUTICAL INDUSTRY ... Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry Recursion Pharmaceuticals Mon, May 13, 2024, 5:00

[Humanist]

Source: Piotr Swat / Shutterstock.com https://finance.yahoo.com/news/cathie-wood-just-bought-3-190057515.htmlRecursion Pharmaceuticals (NASDAQ:RXRX) is using artificial intelligence (AI) to

[Humanist]

THEY ALSO ADDED AN OXFORD AI PROFESSOR TOTHE BOARD. AS WELL..  Recursion Announces Plans to Open New Office in London GlobeNewswireMar 11, 2024, 04:05 AM   LONDON, March 11, 2024 (GLOBE

[whytestocks]

Breaking News: $RXRX Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today2024-02-28 18:44:00 ET Recursion Pharmaceuticals (NASDAQ: RXRX) couldn't get over the hump of Hump Day. Following

[whytestocks]

BREAKING NEWS: $RXRX Recursion Pharmaceuticals Stock Is Sliding Wednesday: What's Going On? | BenzingaRecursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading lower Wednesday after the